Investor Center Home
Corporate Profile
Bellicum is a biopharmaceutical company that has engineered the newest wave of high-performance cellular technology, unleashing the power of potentially curative IO therapies against a wide range of cancers, providing a better tomorrow for more cancer patients.
(Common Stock)
-
(US Dollar)
-
Price
-
Change (%)
-
Volume
-
Exchange
Data as of 04/19/24 12:52 PM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.
